Related Experiment Videos
Biochemically-defined differentiation markers on human early haemopoietic (K562) cells
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1984
Summary
Haemin and the tumor promoter TPA alter surface proteins in human erythroleukaemic (K562) cells. Three key proteins are reduced, indicating potential markers for early haemopoietic differentiation.
Area of Science:
- Cell Biology
- Hematology
- Biochemistry
Background:
- Human erythroleukaemic (K562) cells are a model for studying hematopoietic differentiation.
- Surface protein expression can change during cellular differentiation.
- Previous reports on haemin's effects on K562 cells may be incomplete.
Purpose of the Study:
- To investigate the effects of haemin and the tumor promoter TPA on K562 cell surface protein patterns.
- To identify specific surface proteins that are consistently altered by these inducers.
- To evaluate these proteins as potential markers for early hematopoietic differentiation.
Main Methods:
- Treatment of K562 cells with haemin and TPA.
- Analysis of surface protein expression patterns using proteomic techniques.
- Comparison of protein changes induced by both agents.
Main Results:
- Both haemin and TPA induced significant changes in K562 cell surface protein profiles.
- Three major surface proteins were consistently down-regulated by both haemin and TPA.
- The down-regulated proteins were not identified as solely growth-related.
Conclusions:
- Haemin and TPA are potent modulators of K562 cell surface proteome.
- The identified down-regulated proteins serve as candidate markers for early hematopoietic differentiation.
- These findings provide new insights into K562 cell differentiation markers.